Steven Cohen acquired 1.39 Million Verve Therapeutics shares worth $15.7 Million. That's 0.04% of their equity portfolio (388th largest holding). The investor owns 1.59% of the outstanding Verve Therapeutics stock. The first Verve Therapeutics trade was made in Q1 2023. Since then Steven Cohen bought shares three more times and sold shares on three occasions. The stake costed the investor $7.89 Million, netting the investor a gain of 99% so far.